Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

溃疡性结肠炎 医学 安慰剂 内科学 随机对照试验 胃肠病学 结肠镜检查 灌肠 临床试验 移植 结直肠癌 疾病 病理 癌症 替代医学
作者
Sudarshan Paramsothy,Michael A. Kamm,Nadeem O. Kaakoush,Alissa Walsh,Johan van den Bogaerde,Douglas Samuel,Rupert W. Leong,Susan J. Connor,Watson Ng,Ramesh Paramsothy,Wei Xuan,Enmoore Lin,Hazel M. Mitchell,Thomas J. Borody
出处
期刊:The Lancet [Elsevier BV]
卷期号:389 (10075): 1218-1228 被引量:1067
标识
DOI:10.1016/s0140-6736(17)30182-4
摘要

Summary

Background

The intestinal microbiota is implicated in the pathogenesis of ulcerative colitis. Faecal microbiota transplantation is a novel form of therapeutic microbial manipulation, but its efficacy in ulcerative colitis is uncertain. We aimed to establish the efficacy of intensive-dosing, multidonor, faecal microbiota transplantation in active ulcerative colitis.

Methods

We conducted a multicentre, double-blind, randomised, placebo-controlled trial at three hospitals in Australia. We randomly allocated patients with active ulcerative colitis (Mayo score 4–10) in a 1:1 ratio, using a pre-established randomisation list, to either faecal microbiota transplantation or placebo colonoscopic infusion, followed by enemas 5 days per week for 8 weeks. Patients, treating clinicians, and other study staff were unaware of the assigned treatment. Faecal microbiota transplantation enemas were each derived from between three and seven unrelated donors. The primary outcome was steroid-free clinical remission with endoscopic remission or response (Mayo score ≤2, all subscores ≤1, and ≥1 point reduction in endoscopy subscore) at week 8. Analysis was by modified intention-to-treat and included all patients receiving one study dose. We performed 16S rRNA stool analysis to assess associated microbial changes. This trial is registered with ClinicalTrials.gov, number NCT01896635. The trial has ended; this report presents the final analysis.

Findings

From November, 2013, to May, 2015, 85 patients were enrolled to our trial, of whom 42 were randomly assigned faecal microbiota transplantation and 43 were allocated placebo. One patient assigned faecal microbiota transplantation and three allocated placebo did not receive study treatment and were excluded from the analysis. The primary outcome was achieved in 11 (27%) of 41 patients allocated faecal microbiota transplantation versus three (8%) of 40 who were assigned placebo (risk ratio 3·6, 95% CI 1·1–11·9; p=0·021). Adverse events were reported by 32 (78%) of 41 patients allocated faecal microbiota transplantation and 33 (83%) of 40 who were assigned placebo; most were self-limiting gastrointestinal complaints, with no significant difference in number or type of adverse events between treatment groups. Serious adverse events occurred in two patients assigned faecal microbiota transplantation and in one allocated placebo. Microbial diversity increased with and persisted after faecal microbiota transplantation. Several bacterial taxa were associated with clinical outcome; in particular, the presence of Fusobacterium spp was associated with lack of remission.

Interpretation

Intensive-dosing, multidonor, faecal microbiota transplantation induces clinical remission and endoscopic improvement in active ulcerative colitis and is associated with distinct microbial changes that relate to outcome. Faecal microbiota transplantation is, thus, a promising new therapeutic option for ulcerative colitis. Future work should focus on precisely defining the optimum treatment intensity and the role of donor–recipient matching based on microbial profiles.

Funding

Broad Medical Research Program, Gastroenterological Society of Australia, Mount Sinai (New York) SUCCESS fund, University of New South Wales.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
852应助如意代秋采纳,获得10
刚刚
祝愿发布了新的文献求助10
刚刚
3秒前
3秒前
daoyi完成签到,获得积分10
4秒前
4秒前
5秒前
8秒前
flow完成签到,获得积分10
9秒前
123gg发布了新的文献求助10
9秒前
zong2807完成签到,获得积分10
10秒前
阿菜完成签到,获得积分10
10秒前
泥嚎发布了新的文献求助10
11秒前
13秒前
tuanheqi应助研友_LXjjOZ采纳,获得150
13秒前
酷波er应助北北采纳,获得10
16秒前
田様应助CHRIS采纳,获得10
16秒前
小焦儿完成签到,获得积分10
17秒前
万能图书馆应助坚定白风采纳,获得10
17秒前
丘比特应助小任性采纳,获得10
17秒前
所所应助liziqi采纳,获得10
18秒前
雪白的夏山完成签到,获得积分10
25秒前
失眠的广山完成签到 ,获得积分10
25秒前
30秒前
31秒前
星辰大海应助大喵采纳,获得10
33秒前
34秒前
35秒前
35秒前
keyantong发布了新的文献求助10
35秒前
薛妖怪发布了新的文献求助10
35秒前
小任性发布了新的文献求助10
36秒前
南瓜饼完成签到,获得积分10
37秒前
漂亮白枫发布了新的文献求助10
38秒前
zhxq发布了新的文献求助10
39秒前
39秒前
rhei发布了新的文献求助30
40秒前
42秒前
43秒前
一事无成的研一完成签到 ,获得积分10
44秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989797
求助须知:如何正确求助?哪些是违规求助? 3531910
关于积分的说明 11255394
捐赠科研通 3270563
什么是DOI,文献DOI怎么找? 1805008
邀请新用户注册赠送积分活动 882157
科研通“疑难数据库(出版商)”最低求助积分说明 809190